← Back
Data updated: Jun 28, 2026
LEK PHARM
Generics Pharmaceuticals
LEK PHARM is a generic drug manufacturer with 2 FDA-approved products.
1998
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
LEK PHARM's Key Drugs
LEK PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
LEK PHARM's Recent FDA Approvals
New NDA/BLA approvals for LEK PHARM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
LEK PHARM's Therapeutic Areas
Disease areas where LEK PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
LEK PHARM Pipeline Snapshot
Active clinical trials for LEK PHARM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1998-12-10
- Latest
- 1998-12-10
- Applications
- 3